Aims
To evaluate the effects of a multi-component intervention for smokers hospitalized for atherosclerotic cardiovascular disease (ASCVD) on the participation rate in community-based cessation programs and the use of cessation drugs. Additionally, to explore the impact on the cessation rates at six months.
Methods
A randomized parallel-group study was conducted at a Norwegian secondary care hospital in 2021. The intervention group was: 1) counseled using motivational interviewing techniques during hospitalization; 2) given an information-leaflet, detailing the cessation program; and 3) referred to the community-based smoking cessation treatment including a post-discharge proactive telephone invitation. The control group received usual care and the same information-leaflet containing clear contact details for initiating participation. Data were collected at baseline, one, three and six months.
Results
Among 99 smokers hospitalized with ASCVD, 40 were excluded. Of 59 randomized patients, four were lost to follow-up and 55 completed the study. The mean age was 65.1 (SD 9.3) years, 35% were female, and 88% had smoked > 20 years. Comorbidity was prevalent (mean Charlson score 4.8). The intervention group was more likely to participate in the smoking cessation treatment (48% vs. 7%, difference: 41% [95% CI: 14%, 63%]) and used cessation drugs more frequently (59% vs. 21%, difference: 38% [95% CI: 17%, 59%]). At the six months point prevalence, we observed notable between-group differences in self-reported cessation rate (48% vs. 25%).
Conclusion
The intervention significantly increased the participation rate at community-based smoking cessation programs and the use of cessation drugs among multi-morbid smokers hospitalized for ASCVD.